Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

LGC and CCCMHPIE sign partnership agreement

26 Jun 2013
Tags:  ChemicalPharma
26 June 2013 – LGC and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) today announced that they have signed a partnership agreement at the CPHI Conference in Shanghai.

Under the agreement, LGC will bring its international expertise in the pharmaceutical market and in high product quality to CCCMHPIE member companies and will offer services including:

  • Market assessment and product registration
  • Reference standards and product testing
  • Training and consultancy in quality and laboratory design and operation
Dr Derek Craston, LGC director for Science and Technology, said: “We are proud to be collaborating with the CCCMHPIE, bringing our own international expertise in product quality and registration across the pharmaceuticals and healthcare markets. This announcement is a key element to our international growth strategy and we look forward to sharing our experience in this new developing market.”

Mr. Ni Rulin, president of CCCMHPIE said, “LGC is the global leading research institution focusing on lab services, drug testing and provision of reference standards with a long history of more than 100 years and LGC’s specialised background has been widely acknowledged. We believe that the collaboration between us will provide a special platform for Chinese companies to access the international market.”

CCCMHPIE is the leading and most influential national trade association in China with a mission to promote the international trade and cooperation in medicinal and health products. CCCMHPIE,directly under the Ministry of Commerce of China, has a diverse membership of more than 2,400 companies including most of the major manufacturers and trading companies of pharmaceutical and health products across China. The fields that CCCMHPIE covers range from Traditional Chinese Medicines (TCM), pharmaceuticals, preparations, medical devices and equipment, dressings, biopharmaceuticals, nutraceuticals, functional cosmetics to health products.

• 市场评估与产品注册
• 标准品与产品检测
• 质量、实验室设计及运营的培训与咨询
LGC科学技术部总监Derek Craston博士说:“能与中国医药保健品进出口商会合作,我们深感自豪。我们将发挥我们在制药与保健市场领域产品质量与注册的国际专长。这个协议是我们全球发展战略的重要组成部分,并且我们期待在新兴市场分享我们的经验。”
中国医药保健品进出口商会倪如林会长表示, LGC是全球领先的以实验室服务、药品检测和标准品为主要业务的科研机构,具有100多年的历史以及被广泛认可的专业背景。我们相信医保商会与LGC的合作将为中国医药企业进入国际市场搭建一个专业化服务平台。
LGC 是一家基于科学领域的跨国公司,是集实验室服务、测量标准、基因组学、标准品与能力认证于一体的市场领导者。LGC的业务覆盖了多个市场–包括但不限于食品和农业、政府、制药、生物制药与体育运动–保障了公众安全与健康,同时协助私营和公营领域的客户制定行业规范。
LGC(政府化学家实验室)成立于1842 年。100多年来,LGC行使着英国政府化学家的独特职责。LGC于1996实现私有化,现在LGC由持有多数股权的Bridgepoint公司管理。